Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Manufacturing symbols : Alpmf save search
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-04-23 (Crawled : 00:00) - prnewswire.com
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
granted approval cancer treatment for
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Published: 2024-04-22 (Crawled : 09:00) - prnewswire.com
SMFNF | News | $55.63 -1.2% 24K
|
Finance
|
| O: -0.16%
H: 3.14%
C: 0.04%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.63%
H: 0.0%
C: -0.31%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.8%
H: 0.75%
C: 0.38%
drug company for agreement
Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth
Published: 2024-04-17 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
treatment global growth market
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: -3.69%
H: 5.08%
C: 5.08%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.31%
H: 2.95%
C: 2.08%
IFRX | $1.355 -0.37% -0.37% 71K
|
Health Technology
|
| O: -4.17%
H: 2.17%
C: -5.07%
CLSD | News P | $1.33 -2.92% -3.01% 200K
|
Health Technology
|
| O: 1.61%
H: 0.79%
C: -8.73%
Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034 | DelveInsight
Published: 2024-04-11 (Crawled : 22:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -8.65%
H: 3.19%
C: 1.6%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.0%
H: 0.52%
C: -1.04%
growth market
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published: 2024-04-10 (Crawled : 09:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -0.29%
H: 0.0%
C: -1.97%
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: -0.6%
H: 1.03%
C: 0.52%
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: -2.01%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
JAZZ | $108.38 -1.18% -1.19% 400K
|
Health Technology
|
| O: -1.71%
H: 0.57%
C: 0.37%
disorders system set market
Gene Therapies in Ophthalmology Market to Register Immense Growth at a CAGR of 57.8% by 2034 | DelveInsight
Published: 2024-04-04 (Crawled : 22:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -0.52%
H: 0.71%
C: 0.71%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
SLDB | $8.75 -3.95% -4.11% 140K
|
Health Technology
|
| O: -0.73%
H: 1.3%
C: -1.06%
growth market
Retinitis Pigmentosa Market to Grow Rapidly at a CAGR of 16.8% by 2034 | DelveInsight
Published: 2024-04-02 (Crawled : 22:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -0.65%
H: 2.43%
C: -0.28%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
market
China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for enfortumab vedotin with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Published: 2024-03-28 (Crawled : 15:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.82%
H: 0.0%
C: -2.54%
keytruda license bladder cancer treatment medical application advanced
Astellas Receives Permanent J-code for IZERVAY™ (avacincaptad pegol intravitreal solution) for Geographic Atrophy
Published: 2024-03-26 (Crawled : 13:00) - ivericbio.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.65%
H: 3.36%
C: 3.17%
Astellas' VYLOY™ (zolbetuximab) Approved in Japan for Treatment of Gastric Cancer
Published: 2024-03-26 (Crawled : 12:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.65%
H: 3.36%
C: 3.17%
japan approved cancer treatment
Astellas Receives Positive CHMP Opinion for XTANDI™ in Additional Recurrent Early Prostate Cancer Treatment Setting
Published: 2024-03-22 (Crawled : 12:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: -0.54%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 2.26%
H: 0.0%
C: -2.65%
chmp positive cancer treatment
Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published: 2024-03-22 (Crawled : 04:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: -0.54%
H: 0.0%
C: 0.0%
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -1.71%
H: 0.0%
C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 2.67%
H: 0.0%
C: -1.58%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 2.26%
H: 0.0%
C: -2.65%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.4%
H: 0.33%
C: -0.45%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.45%
H: 0.53%
C: -0.35%
market
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024
Published: 2024-03-19 (Crawled : 10:00) - globenewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -2.95%
H: 3.7%
C: 3.32%
OPT | News | $3.46 2.98% 2.89% 8.2K
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: -0.29%
opt-302 macular key
Silicon carbide (SiC) market size to grow at a CAGR of 12.33% from 2022 to 2027, Increase in demand for SiC fibers in the aerospace sector to boost the market, Technavio
Published: 2024-03-11 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 1.55%
H: 0.82%
C: 0.16%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.41%
H: 5.06%
C: 4.01%
DOW | $56.98 0.42% 0.0% 5M
|
Process Industries
|
| O: 0.14%
H: 1.95%
C: 1.31%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.08%
H: 0.82%
C: 0.67%
market
Electronic Health Records Market size is set to grow by USD 32.27 bn from 2023-2027, benefits of EHR leading to rise in adoption boost the market- Technavio
Published: 2024-03-11 (Crawled : 14:30) - prnewswire.com
CCLD | $1.14 1.72% 15K
|
Manufacturing
|
| O: 0.0%
H: 2.99%
C: -2.99%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 1.55%
H: 0.82%
C: 0.16%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.41%
H: 5.06%
C: 4.01%
EVCM | News | $9.33 0.22% 0.21% 140K
|
Information
|
| O: -0.31%
H: 3.15%
C: 1.68%
GPN | $127.47 0.47% 0.0% 1.4M
|
Technology Services
|
| O: -0.05%
H: 0.7%
C: 0.54%
DELL | News | $120.2 -0.36% -2.04% 5.8M
|
Electronic Technology
|
| O: -0.66%
H: 1.17%
C: 0.33%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.08%
H: 0.82%
C: 0.67%
health set benefits market
Laboratory Information Management System (LIMS) Market size is set to grow by USD 907.08 mn from 2023-2027, Abbott Laboratories, Computing Solutions, Novatek International and more key players- Technavio
Published: 2024-03-11 (Crawled : 14:30) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 1.55%
H: 0.82%
C: 0.16%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.41%
H: 5.06%
C: 4.01%
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: -0.57%
H: 0.98%
C: 0.88%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.08%
H: 0.82%
C: 0.67%
management international system set key market
Vaccine research market size to grow at a CAGR of 9.88% from 2022 to 2027, Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players, Technavio
Published: 2024-03-11 (Crawled : 14:30) - prnewswire.com
CMXHF | $176.0 -19.21% 50
|
n/a
|
| O: 0.41%
H: 0.0%
C: 0.0%
CSLLY | $90.71 3.3% 35K
|
n/a
|
| O: -4.92%
H: 3.76%
C: 3.44%
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -3.4%
H: 1.49%
C: 1.49%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 1.55%
H: 0.82%
C: 0.16%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.41%
H: 5.06%
C: 4.01%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.6%
H: 0.19%
C: 0.09%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.08%
H: 0.82%
C: 0.67%
pharma vaccine astrazeneca research key market
FDA Grants Orphan Drug and Pediatric Exclusivities for CRESEMBA® (isavuconazonium sulfate) for Invasive Aspergillosis and Invasive Mucormycosis in Children
Published: 2024-03-11 (Crawled : 13:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.41%
H: 5.06%
C: 4.01%
cresemba fda drug children grants
Astellas Initiates Phase 3 Clinical Studies of Fezolinetant for VMS Associated with Menopause in Japan
Published: 2024-03-03 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
|
| O: 4.78%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -0.5%
H: 0.29%
C: -0.13%
japan
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.